Evidence map›Paper›PMID 34042556›Full record

ReviewExpert opinion on pharmacotherapy2021

Can pharmacotherapy improve treatment outcomes in people with co-occurring major depressive and cocaine use disorders?

Gustavo A Angarita, Hasti Hadizadeh, Ignacio Cerdena, Marc N Potenza

Open access · greenAbstract readReview
In one paragraph

Review in Expert opinion on pharmacotherapy, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed, 1 pooled it
1.5field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 1 synthesis or guideline pooled it, 11 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Review
  4. Dopamine DJournal of medicinal chemistry · 2023
    Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Gustavo A AngaritaDepartment of Psychiatry, Yale University School of Medicine, New Haven, CT, USA.
Hasti HadizadehDepartment of Psychiatry, Yale University School of Medicine, New Haven, CT, USA.
Ignacio CerdenaDepartment of Psychiatry, Yale University School of Medicine, New Haven, CT, USA.
Marc N PotenzaDepartment of Psychiatry, Yale University School of Medicine, New Haven, CT, USA.ORCID 0000-0002-6323-1354
Yale University · US

Funding

Yale Clinical and Translational Science Award (U Component)UL1TR001863 · NCATS · YALE UNIVERSITY · PI John H. Krystal, LUCILA OHNO-MACHADO · 2016 to 2026
$102.9M
Functional networks related to cocaine dependence and its treatment and relapseR01DA039136 · NIDA · YALE UNIVERSITY · PI POTENZA, MARC N · 2016 to 2018
$754k
GLP-1 Agonism for Blocking Cocaine Euphoria and Self-AdministrationR21DA040914 · NIDA · YALE UNIVERSITY · PI ANGARITA, GUSTAVO ADOLFO · 2016 to 2017
$461k
Assessing Glutamate Homeostasis in Cocaine Addiction Using 7T 1H-MRSR21DA043055 · NIDA · YALE UNIVERSITY · PI ANGARITA, GUSTAVO ADOLFO · 2017 to 2018
$461k
NCATS NIH HHS UL1 TR001863NIDA NIH HHS R01 DA039136NIDA NIH HHS R21 DA040914NIDA NIH HHS R21 DA043055
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Central Nervous System StimulantsCocaineMajor Depressive DisorderSubstance-Related DisordersHumansTreatment OutcomeCentral Nervous System StimulantsCocaineaddictive behaviorscocaine use disorderdopamineglutamatemajor depressive disorderpharmacotherapystimulantsSubstance-related disorderstreatment development

Identifiers

PMID34042556
PMCPMC8440354
OpenAlexW3165174062

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.